²»Á¼Ñо¿Ëù

News

Stay up to date on the latest company news:
09 October 2024

²»Á¼Ñо¿Ëù Appoints Gerben Moolhuizen as Chief Executive Officer

18 March 2024

²»Á¼Ñо¿Ëù selected for funding project by KMU-innovativ, an initiative from Germany‘s Federal Ministry of Education and Research (BMBF)

18 October 2022

²»Á¼Ñо¿Ëù Appoints Thomas Bogenrieder as Chief Medical Officer

12 August 2022

²»Á¼Ñо¿Ëù---arenaviruses take on cancer

14 October 2021

²»Á¼Ñо¿Ëù Completes Series A Extension Bringing Total Raised to EUR 43 Million

05 February 2020

²»Á¼Ñо¿Ëù Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts

15 October 2019

²»Á¼Ñо¿Ëù Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer

Events

Want to get in touch with the ²»Á¼Ñо¿Ëù Team? Meet us at the following events:
October 27-30, 2024

IOVC 16th Annual International Oncolytic Virotherapy Conference 2024

Location: Rotterdam, NL

Presentation: 2 posters

Presenters: Jörg Vollmer, CSO; Sarah-Kim Friedrich-Becker, Senior Principal Scientist

Date: October 27-30, 2024

November 4-6, 2024

BIO-Europe

Location: Stockholm, Sweden

Date: November 4-6, 2024

January 13-16, 2025

J.P. Morgan Healthcare Conference 2025

Location: San Francisco, USA

Date: January 13-16, 2025